Read + Share
Amedeo Smart
Independent Medical Education
Maynard G, Kannan R, Liu J, Wang W, et al. Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial. Lancet Neurol 2023;22:672-684.PMID: 37479373
Email
LinkedIn
Privacy Policy